查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1797989

2032 年精神健康设备和平台新兴市场预测：按产品类型、治疗方法、年龄层、技术、应用、最终用户和地区进行的全球分析

Emerging Mental Health Devices and Platforms Market Forecasts to 2032 - Global Analysis By Product Type (Platforms and Devices), Therapy, Age Group, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球新兴心理健康设备和平台市场预计在 2025 年达到 51 亿美元，到 2032 年将达到 174 亿美元，预测期内的复合年增长率为 19.3%。

新兴心理健康设备和平台是指旨在诊断、监测和管理心理健康状况的先进数位工具和技术。这些设备包括穿戴式生物感测器、神经刺激设备、人工智慧聊天机器人、行动应用程式和虚拟治疗平台。它们能够即时追踪心理状态，提供远端咨询和个人化治疗建议。在心理健康意识不断增强和远端医疗广泛应用的推动下，这些创新正在彻底改变心理健康服务的提供方式，提高服务的可及性，减少污名化，并促进不同人群的积极情绪健康。

根据美国国家精神疾病联盟 (2023) 的数据，美国五分之一的成年人会患有精神疾病，因此开发能够提供即时支援和监控的人工智慧工具至关重要。

远端医疗服务的采用率不断提高

远端医疗服务的快速普及是新兴心理健康设备和平台市场的主要驱动力。对便捷便捷的心理健康支援服务的需求日益增长，推动了数位咨询和基于应用程式的治疗的广泛应用。远端医疗消除了地域障碍，减少了污名化，并实现了患者与治疗师之间的即时互动。支持性发展、保险覆盖范围的扩大以及患者对虚拟护理日益增长的偏好，进一步加速了已开发地区和新兴地区的市场发展，为数位心理健康创新提供了持续的动力。

设备开发安装成本高

开发和部署心理健康设备的高成本是市场成长的主要限制因素。设计经临床检验且易于使用的硬件，例如神经刺激设备和可穿戴生物感测器，需要大量的研发投入和合规性。新兴企业和小型企业往往面临资金和生产扩充性的困境。此外，与远端医疗平台整合并确保资料安全通讯协定也增加了开发的复杂性，从而减缓了市场渗透，尤其是在资源匮乏的地区和服务不足的医疗机构中。

远距心理健康监测需求不断成长

远距心理健康监测需求的不断增长代表着该市场的巨大机会。能够即时追踪情绪、睡眠、心率变异性和压力水平的穿戴式装置和行动应用程式正日益受到患者和临床医生的青睐。这些工具能够提供早期疗育、个人化照护以及临床以外的持续支持。随着心理健康意识的不断增强以及科技应用的日益普及，尤其是在年轻人群体中，远端监测解决方案有望成为主动心理健康护理的核心组成部分。

数位治疗的监管障碍

严格的数位疗法法律规范对新兴的精神健康设备和平台市场构成了重大威胁。要获得FDA和EMA等机构的核准，需要进行严格的临床试验、资料隐私保护，并遵守不断发展的远端医疗法规。这些挑战会延迟产品上市，并增加上市成本。此外，报销政策和数位疗法分类的不确定性也为开发者带来了不确定性，扼杀了创新，并限制了经临床验证的数位精神健康解决方案的可用性。

COVID-19的影响：

由于心理困扰加剧，且获得面对面护理的机会有限，COVID-19 疫情大大加速了数位心理健康解决方案的使用。封锁和隔离措施推动了对虚拟治疗平台、心理健康应用程式和远端监控工具的需求。这场危机检验疗法的扩充性，并增加了对心理健康新兴企业的资金投入。随着混合护理模式的日益普及，心理健康护理格局发生了重塑，数位平台作为长期心理健康策略的重要组成部分的地位也得到巩固。

预计平台部分将成为预测期内最大的部分

受应用程式为基础的疗法、虚拟咨询和心理健康计画的普及推动，平台细分市场预计将在预测期内占据最大市场占有率。这些平台为患者和医疗保健提供者提供便利、可客製化、经济高效且扩充性的解决方案。引导式冥想、主导聊天机器人和视讯治疗课程等功能使平台成为各年龄层的首选。随着数位心理健康生态系统的成熟，基于平台的解决方案在用户采用率和市场占有率方面将继续超越以设备为中心的模式。

预计认知行为疗法 (CBT) 领域在预测期内将以最高的复合年增长率成长。

认知行为疗法 (CBT) 领域预计将在预测期内实现最高成长率，这得益于其在治疗焦虑、忧郁症和压力相关疾病方面已证实的临床有效性。透过应用程式和线上平台以数位化方式交付的 CBT 模组提供了一种便捷、结构化且经济高效的治疗方案。人工智慧驱动的 CBT 聊天机器人和自导式程式的兴起正在使治疗更加民主化，尤其对于偏远和服务欠缺地区的患者。随着心理健康素养的提高，对 CBT主导解决方案的需求将持续成长。

比最大的地区

预计亚太地区将在预测期内占据最大的市场占有率，这得益于心理健康意识的不断增强、快速的都市化以及智慧型手机的高普及率。中国、印度和日本等国的政府和私人企业正在投资远端医疗基础设施和数位健康平台。文化上对精神疾病的非人性化以及职场心理健康倡议的增多，进一步促进了相关技术的采用。该地区不断增长的年轻人口和不断扩展的数位生态系统，正在推动心理健康应用程式和虚拟治疗工具的快速普及。

复合年增长率最高的地区：

预计北美将在预测期内实现最高的复合年增长率，这得益于先进的医疗基础设施、高度的心理健康意识以及对数位疗法的支持性法律规范。主要企业的涌现和强大的新兴企业生态系统将推动创新。优惠的报销政策、政府对远距心理健康的资助以及雇主和保险公司日益普及的采用，都推动了该地区的快速成长。此外，疫情过后人们对心理健康的担忧日益加剧，将继续推动该地区对数位心理健康解决方案的需求。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球新兴心理健康设备和平台市场（按产品类型）

  • 平台
  • 装置

6. 全球新兴心理健康设备与平台市场（依治疗方法）

  • 认知行为治疗（CBT）
  • 电疗
  • 其他治疗方法

7. 全球新兴心理健康设备与平台市场（依年龄层）

  • 儿童和青少年
  • 成人
  • 老年人

8. 全球新兴心理健康设备和平台市场（按技术）

  • 穿戴式科技
  • 行动应用程式
  • 平台和远端医疗

9. 全球新兴心理健康设备与平台市场（按应用）

  • 自我保健和健康
  • 治疗
  • 心理健康评估与诊断
    • 压力
    • 焦虑
    • 忧郁症
    • 躁郁症
  • 其他用途

10. 全球新兴心理健康设备和平台市场（按最终用户）

  • 病人
  • 医疗机构（医院、诊所）
  • 雇主
  • 其他最终用户

11. 全球新兴心理健康设备和平台市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章：公司概况

  • Acadia Healthcare
  • AbleTo Inc.
  • Amelia Virtual Care
  • CareTech Holding PLC
  • Clarigent Health
  • Compass Pathways
  • Electromedical Products International（EPI）
  • Eli Lilly and Co.
  • Feel Therapeutics
  • Flow Neuroscience
  • Headspace Inc.
  • Pear Therapeutics
  • Quartet Health
  • Spring Health
  • Talkspace Inc.
  • Teladoc Health Inc.
  • Woebot Health
Product Code: SMRC30359

According to Stratistics MRC, the Global Emerging Mental Health Devices and Platforms Market is accounted for $5.1 billion in 2025 and is expected to reach $17.4 billion by 2032 growing at a CAGR of 19.3% during the forecast period. Emerging mental health devices and platforms refer to advanced digital tools and technologies aimed at diagnosing, monitoring, and managing mental health conditions. These include wearable biosensors, neurostimulation devices, AI-powered chatbots, mobile apps, and virtual therapy platforms. They enable real-time mental state tracking, remote consultations, and personalized treatment recommendations. Spurred by increased mental health awareness and telehealth adoption, these innovations are revolutionizing mental healthcare delivery, improving accessibility, reducing stigma, and promoting proactive emotional well-being across diverse populations.

According to the National Alliance on Mental Illness (2023), with 1 in 5 U.S. adults experiencing mental illness, there is a growing emphasis on developing AI-powered tools that can provide real-time support and monitoring.

Market Dynamics:

Driver:

Increasing adoption of telehealth services

The rapid adoption of telehealth services is significantly driving the emerging mental health devices and platforms market. With growing demand for accessible and convenient mental health support, digital consultations and app-based therapies are gaining widespread traction. Telehealth breaks geographical barriers, reduces stigma, and enables real-time patient-therapist interaction. Government support, insurance coverage expansions, and evolving patient preferences toward virtual care are further accelerating market adoption across both developed and developing regions, creating sustained momentum for digital mental health innovation.

Restraint:

High device development and deployment costs

High costs associated with developing and deploying mental health devices pose a major restraint to market growth. Designing clinically validated, user-friendly hardware-such as neurostimulators and wearable biosensors-requires substantial R&D investment and regulatory compliance. Startups and small companies often struggle with limited funding and production scalability. Additionally, ensuring integration with telehealth platforms and data security protocols further adds to development complexity, slowing market penetration, particularly in resource-constrained environments or among underserved healthcare providers.

Opportunity:

Growing demand for remote mental health monitoring

The growing demand for remote mental health monitoring represents a major opportunity in the market. Wearables and mobile applications capable of tracking mood, sleep, heart rate variability, and stress levels in real-time are gaining popularity among patients and clinicians. These tools allow early intervention, personalized care, and continuous support beyond clinical settings. As awareness of mental well-being increases and technology adoption rises, especially among younger populations, remote monitoring solutions are poised to become central to proactive mental healthcare.

Threat:

Regulatory hurdles for digital therapeutics

Strict regulatory frameworks for digital therapeutics present a critical threat to the emerging mental health devices and platforms market. Gaining approval from agencies such as the FDA or EMA requires rigorous clinical trials, data privacy safeguards, and compliance with evolving telehealth laws. These challenges delay product launches and increase go-to-market costs. Moreover, uncertainty in reimbursement policies and classification of digital therapies creates ambiguity for developers, discouraging innovation and limiting the availability of clinically proven digital mental health solutions.

Covid-19 Impact:

The COVID-19 pandemic dramatically accelerated the use of digital mental health solutions due to rising psychological distress and limited in-person care access. Lockdowns and isolation drove demand for virtual therapy platforms, mental health apps, and remote monitoring tools. The crisis validated the scalability of digital therapeutics and increased funding toward mental health tech startups. As hybrid care models become the norm, COVID-19 has reshaped the mental healthcare landscape, solidifying digital platforms as essential components of long-term mental health strategies.

The platforms segment is expected to be the largest during the forecast period

The platforms segment is expected to account for the largest market share during the forecast period, owing to widespread adoption of app-based therapies, virtual consultations, and mental wellness programs. These platforms offer scalable solutions that are accessible, customizable, and cost-effective for both patients and providers. Features like guided meditation, AI-driven chatbots, and video therapy sessions make platforms a preferred choice across age groups. As the digital mental health ecosystem matures, platform-based solutions continue to outpace device-centric models in user adoption and market presence.

The cognitive behavioral therapy (CBT) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cognitive behavioral therapy (CBT) segment is predicted to witness the highest growth rate, impelled by its proven clinical efficacy in treating anxiety, depression, and stress-related disorders. Digitally delivered CBT modules via apps and online platforms offer accessible, structured, and cost-effective treatment options. The rise of AI-powered CBT chatbots and self-guided programs has democratized access, particularly for patients in remote or underserved areas. As mental health literacy increases, demand for CBT-driven solutions continues to accelerate.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by rising mental health awareness, rapid urbanization, and strong smartphone penetration. Governments and private players across countries like China, India, and Japan are investing in telehealth infrastructure and digital wellness platforms. Cultural destigmatization of mental illness and increasing workplace mental health initiatives further contribute to adoption. The growing youth population and expanding digital ecosystems in the region are fostering rapid uptake of mental health apps and virtual therapy tools.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, attributed to advanced healthcare infrastructure, high mental health awareness, and supportive regulatory frameworks for digital therapeutics. The presence of leading mental health tech companies and a strong startup ecosystem accelerates innovation. Favorable reimbursement policies, government funding for tele-mental health, and increasing adoption by employers and insurers are contributing to rapid growth. Additionally, growing concerns around post-pandemic mental well-being continue to drive demand for digital mental health solutions in the region.

Key players in the market

Some of the key players in Emerging Mental Health Devices and Platforms Market include Acadia Healthcare, AbleTo Inc., Amelia Virtual Care, CareTech Holding PLC, Clarigent Health, Compass Pathways, Electromedical Products International (EPI), Eli Lilly and Co., Feel Therapeutics, Flow Neuroscience, Headspace Inc., Pear Therapeutics, Quartet Health, Spring Health, Talkspace Inc., Teladoc Health Inc. and Woebot Health.

Key Developments:

In June 2025, Acadia Healthcare expanded its digital mental health offerings in June 2025 by integrating new AI-powered therapy platforms for anxiety and depression management. These tools provide scalable remote patient engagement and real-time monitoring. Acadia also partnered with health insurers in the U.S. to improve reimbursement pathways.

In May 2025, AbleTo introduced expanded virtual care programs in May 2025 targeting chronic disease patients with co-morbid mental health conditions. The platform integrates evidence-based cognitive behavioral therapy (CBT) with personalized coaching, improving outcomes and reducing hospital readmissions.

In April 2025, Amelia Virtual Care launched an AI-driven chatbot in April 2025 to deliver 24/7 cognitive behavioral support and crisis intervention. The virtual assistant guides users through coping strategies and facilitates clinician escalation when needed.

Product Types Covered:

  • Platforms
  • Devices

Therapies Covered:

  • Cognitive Behavioral Therapy (CBT)
  • Electrotherapy
  • Other Therapies

Age Groups Covered:

  • Children/Adolescents
  • Adults
  • Seniors/Geriatric

Technologies Covered:

  • Wearable Tech
  • Mobile Apps
  • Platforms & Telemedicine

Applications Covered:

  • Self Management & Wellbeing
  • Treatment
  • Mental Health Assessment & Diagnosis
  • Other Applications

End Users Covered:

  • Patients
  • Providers (Hospitals, Clinics)
  • Employers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Emerging Mental Health Devices and Platforms Market, By Product Type

  • 5.1 Introduction
  • 5.2 Platforms
  • 5.3 Devices

6 Global Emerging Mental Health Devices and Platforms Market, By Therapy

  • 6.1 Introduction
  • 6.2 Cognitive Behavioral Therapy (CBT)
  • 6.3 Electrotherapy
  • 6.4 Other Therapies

7 Global Emerging Mental Health Devices and Platforms Market, By Age Group

  • 7.1 Introduction
  • 7.2 Children/Adolescents
  • 7.3 Adults
  • 7.4 Seniors/Geriatric

8 Global Emerging Mental Health Devices and Platforms Market, By Technology

  • 8.1 Introduction
  • 8.2 Wearable Tech
  • 8.3 Mobile Apps
  • 8.4 Platforms & Telemedicine

9 Global Emerging Mental Health Devices and Platforms Market, By Application

  • 9.1 Introduction
  • 9.2 Self Management & Wellbeing
  • 9.3 Treatment
  • 9.4 Mental Health Assessment & Diagnosis
    • 9.4.1 Stress
    • 9.4.2 Anxiety
    • 9.4.3 Depression
    • 9.4.4 Bipolar Disorder
  • 9.5 Other Applications

10 Global Emerging Mental Health Devices and Platforms Market, By End User

  • 10.1 Introduction
  • 10.2 Patients
  • 10.3 Providers (Hospitals, Clinics)
  • 10.4 Employers
  • 10.5 Other End Users

11 Global Emerging Mental Health Devices and Platforms Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Acadia Healthcare
  • 13.2 AbleTo Inc.
  • 13.3 Amelia Virtual Care
  • 13.4 CareTech Holding PLC
  • 13.5 Clarigent Health
  • 13.6 Compass Pathways
  • 13.7 Electromedical Products International (EPI)
  • 13.8 Eli Lilly and Co.
  • 13.9 Feel Therapeutics
  • 13.10 Flow Neuroscience
  • 13.11 Headspace Inc.
  • 13.12 Pear Therapeutics
  • 13.13 Quartet Health
  • 13.14 Spring Health
  • 13.15 Talkspace Inc.
  • 13.16 Teladoc Health Inc.
  • 13.17 Woebot Health

List of Tables

  • Table 1 Global Emerging Mental Health Devices and Platforms Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Emerging Mental Health Devices and Platforms Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Emerging Mental Health Devices and Platforms Market Outlook, By Platforms (2024-2032) ($MN)
  • Table 4 Global Emerging Mental Health Devices and Platforms Market Outlook, By Devices (2024-2032) ($MN)
  • Table 5 Global Emerging Mental Health Devices and Platforms Market Outlook, By Therapy (2024-2032) ($MN)
  • Table 6 Global Emerging Mental Health Devices and Platforms Market Outlook, By Cognitive Behavioral Therapy (CBT) (2024-2032) ($MN)
  • Table 7 Global Emerging Mental Health Devices and Platforms Market Outlook, By Electrotherapy (2024-2032) ($MN)
  • Table 8 Global Emerging Mental Health Devices and Platforms Market Outlook, By Other Therapies (2024-2032) ($MN)
  • Table 9 Global Emerging Mental Health Devices and Platforms Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 10 Global Emerging Mental Health Devices and Platforms Market Outlook, By Children/Adolescents (2024-2032) ($MN)
  • Table 11 Global Emerging Mental Health Devices and Platforms Market Outlook, By Adults (2024-2032) ($MN)
  • Table 12 Global Emerging Mental Health Devices and Platforms Market Outlook, By Seniors/Geriatric (2024-2032) ($MN)
  • Table 13 Global Emerging Mental Health Devices and Platforms Market Outlook, By Technology (2024-2032) ($MN)
  • Table 14 Global Emerging Mental Health Devices and Platforms Market Outlook, By Wearable Tech (2024-2032) ($MN)
  • Table 15 Global Emerging Mental Health Devices and Platforms Market Outlook, By Mobile Apps (2024-2032) ($MN)
  • Table 16 Global Emerging Mental Health Devices and Platforms Market Outlook, By Platforms & Telemedicine (2024-2032) ($MN)
  • Table 17 Global Emerging Mental Health Devices and Platforms Market Outlook, By Application (2024-2032) ($MN)
  • Table 18 Global Emerging Mental Health Devices and Platforms Market Outlook, By Self Management & Wellbeing (2024-2032) ($MN)
  • Table 19 Global Emerging Mental Health Devices and Platforms Market Outlook, By Treatment (2024-2032) ($MN)
  • Table 20 Global Emerging Mental Health Devices and Platforms Market Outlook, By Mental Health Assessment & Diagnosis (2024-2032) ($MN)
  • Table 21 Global Emerging Mental Health Devices and Platforms Market Outlook, By Stress (2024-2032) ($MN)
  • Table 22 Global Emerging Mental Health Devices and Platforms Market Outlook, By Anxiety (2024-2032) ($MN)
  • Table 23 Global Emerging Mental Health Devices and Platforms Market Outlook, By Depression (2024-2032) ($MN)
  • Table 24 Global Emerging Mental Health Devices and Platforms Market Outlook, By Bipolar Disorder (2024-2032) ($MN)
  • Table 25 Global Emerging Mental Health Devices and Platforms Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 26 Global Emerging Mental Health Devices and Platforms Market Outlook, By End Users (2024-2032) ($MN)
  • Table 27 Global Emerging Mental Health Devices and Platforms Market Outlook, By Patients (2024-2032) ($MN)
  • Table 28 Global Emerging Mental Health Devices and Platforms Market Outlook, By Providers (Hospitals, Clinics) (2024-2032) ($MN)
  • Table 29 Global Emerging Mental Health Devices and Platforms Market Outlook, By Employers (2024-2032) ($MN)
  • Table 30 Global Emerging Mental Health Devices and Platforms Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.